Pharmaceutical Contract Manufacturing Market 2019-2029

1. Report Overview 1.1 Global Pharmaceutical Contract Manufacturing Market Segmentation 1.2 Global Pharmaceutical Contract Manufacturing Market Overview 1.3 Why You Should Read This Report 1.4 How This Report Delivers 1.5 Key Questions Answered by This Analytical Report 1.6 Who is This Report For? 1.7 Methodology 1.8 Frequently Asked Questions (FAQ) 1.9 Associated Visiongain Reports 1.10 About Visiongain 2. Introduction to Pharmaceutical Contract Manufacturing 2.1 What is Pharmaceutical Contract Manufacturing? 2.2 The Benefits of Outsourcing in the Pharmaceutical Market 2.3 Pharmaceutical Contract Manufacturing Services 2.4 Strategy and Tactics: The Importance of Outsourcing Wisely 2.5 Trends in Contract Manufacturing, 2018-2029 2.6 Pharmaceutical Contract Manufacturing: Market Segmentation 3. Pharmaceutical Contract Manufacturing: World Market 2019-2029 3.1 Pharmaceutical Contract Manufacturing Market: 3.1.1 Contract Manufacturing is the Most Mature Pharma Outsourcing Sector 3.1.2 The Pharma Contract Manufacturing Market by Sector 2018 3.2 Pharma Contract Manufacturing: Overall Market Forecast 2019-2029 3.2.1 Changing Market Shares by Segment 2018-2029 3.2.2 Drivers for Growth in the Contract Manufacturing Market to 2029 3.2.3 Generics: A Driver or Restraint? 3.2.4 Other Contract Manufacturing Services Market: Outlook and Forecast, 2019-2029 3.2.4.1 Increasing Demand for Formulation Development Services 4. The Contract API Manufacturing Services Submarket 2019-2029 4.1 The Contract API Manufacturing Submarket 4.1.1 Chemical APIs Will Experience Resurgence after the Shift of Focus to Biological APIs 4.1.2 The API Manufacturing Submarket by Sector, 2018 4.2 The Contract API Manufacturing Submarket: Outlook and Forecast 2019-2029 4.2.1 Drivers for Growth in the API Submarket to 2029 4.2.2 The Potential for Microreactors in Commercial Manufacturing to 2029 4.2.3 How Will New EU Regulations Impact the API Manufacturing Submarket? 4.2.4 Contract API Manufacturing Submarket Restraint 2019-2029 4.2.4.1 Backwards Integration for Generics Manufacturers 4.3 The Contract Generic API Manufacturing Submarket 2019-2029 4.3.1 The Contract Generic API Manufacturing Submarket Forecast 2019-2029 4.3.2 The Contract Generic API Manufacturing Submarket Drivers and Restraints to 2029 4.3.2.1 The US Generic Drug User Fee Act and API Manufacturing 4.4 The Contract HPAPI Manufacturing Submarket 2015-2028 4.4.1 Challenges and Opportunities in High Containment Manufacturing 4.4.2 Company Investment into HPAPI Manufacturing Facilities: Growth Increases in the HPAPI Manufacturing Sector 4.4.3 The Contract HPAPI Manufacturing Submarket Forecast 2018-2029 4.4.4 The Contract HPAPI Manufacturing Submarket Drivers and Restraints to 2029 5. The Contract FDF Manufacturing Services Submarket 2019-2029 5.1 The Contract FDF Manufacturing Submarket, 2018 5.1.1 Solid Dosage Manufacturing Leads the Market 5.1.2 CMOs Report High Demand for Softgel Formulations 5.2 The Contract FDF Manufacturing Submarket Forecast 2019-2029 5.2.1 Complex Molecule Manufacturing Will Drive Growth to 2029 5.2.2 What Will Restrain Growth in FDF Outsourcing? 5.3 The Contract Solid Dosage Manufacturing Submarket 2019-2029 5.3.1 How Will Revenue for Solid Dosage Manufacturing Grow to 2029? 5.3.2 The Solid Dosage Manufacturing Submarket Drivers and Restraints 2019-2029 5.3.2.1 Will Product Reformulation Drive Growth to 2029? 5.4 The Contract Injectable Dosage Manufacturing Submarket 2019-2029 5.4.1 The Contract Injectable Dosage Manufacturing Submarket Forecast 2019-2029 5.4.1.1 Drug Shortages Offer Opportunity to CMOs in the Short-Term 5.4.2 Demand for Biopharma Manufacturing Will Drive Growth 2019-2029 5.4.2.1 Interest in Antibody-Drug Conjugate Development Is Growing 5.4.2.3 Challenges in Manufacturing Antibody-Drug Conjugates 5.4.3 Lyophilisation and Aseptic Filling Demand Will Rise 5.4.3.1 Will Spray Drying Replace Lyophilisation in FDF Manufacturing? 6. Leading National Markets for Pharmaceutical Contract Manufacturing 2019-2029 6.1 Leading National Markets for Pharmaceutical Contract Manufacturing, 2018 6.1.1 Challenges in Assessing the Market: Supply versus Demand 6.1.2 Leading National Pharmaceutical Contract Manufacturing Markets: Revenue Forecasts 2019-2029 6.1.3 Pharmaceutical Manufacturing in the US: Regulatory Oversight, 2018 6.1.4 Controlling Foreign Manufacturing Sites 6.1.5 What Impact Will the GDUFA 2012 Have on Foreign Manufacturing? 6.1.6 Outsourcing and US Manufacturing Regulations 6.1.7 Increased Demand for Domestic API Manufacturing? 6.2 The US Contract Manufacturing Market Forecast 2019-2029 6.3 Canada Contract Manufacturing Market Forecast 2019-2029 6.4 Outlook for Pharmaceutical Contract Manufacturing in the EU 6.4.1 The EU is the Leading Destination for Pharmaceutical Contract Manufacturing 6.4.2 Regulatory Aspects of Pharma Manufacturing in the EU 6.4.2.1 The European Commission Amends Annex 16 6.4.2.2 The Falsified Medicine Directive: Controlling API Imports 6.4.3 Biopharma Manufacturing Demand Will Rise 6.4.4 The EU Contract Manufacturing Market Forecast 2019-2029 6.4.5 Germany: The Leading EU Destination for API and FDF Manufacturing 6.4.5.1 Demand for Contract Manufacturing in Germany: Revenue Forecast 2019-2029 6.4.6 CMOs Account for a Third of Manufacturing Sites in France 6.4.6.1 French Pharma Contract Manufacturing Market Forecast 2019-2029 6.4.7 Italy: Strong API Manufacturing Traditions 6.4.7.1 Revenue Forecast for the Italian Pharma Contract Manufacturing Market 2019-2029 6.4.8 Spain: How Will Demand for Manufacturing Services Grow? 6.4.9 UK: Pharmaceutical Contract Manufacturing Market Forecast 2019-2029 6.5 Pharma Contract Manufacturing in Japan to 2029 6.5.1 Pharmaceutical Manufacturing Regulations in Japan 6.5.1.1 The Pharmaceutical Affairs Law 6.5.2 Greater API Outsourcing to Drive Japanese Market Growth to 2028 In Spite of Currency Devaluation Weakening the Economy 7. Leading Emerging Markets for Pharmaceutical Contract Manufacturing Market 2019-2029 7.1 Pharmaceutical Contract Manufacturing in Developing Countries 7.1.1 Outsourcing to Emerging National Markets from Developed Markets 7.1.1.1 Demand Will Increase for Services in India and China 7.1.2 Domestic Demand for Pharmaceutical Contract Manufacturing Services 7.1.3 Pharmaceutical Contract Manufacturing: Leading Emerging National Market Forecasts 2019-2029 7.2 Chinese Demand for Pharma Contract Manufacturing Services 2019-2029 7.2.1 Improved Manufacturing Regulations in China 7.2.1.1 Regulations for Excipients and Guidance for API Manufacturing 7.2.1.2 What Are the Consequences to Stricter Manufacturing Regulations in China? 7.2.2 Chinese CMOs Are Investing in Biopharma Manufacturing 7.2.3 China Pharma Contract Manufacturing Market Forecast 2019-2029 7.3 India: CMOs with Strong Infrastructure and Growing Expertise 7.3.1 Regulatory Outlook for Indian Pharma Manufacturing 7.3.1.1 Stricter Quality Standards to Ensure Compliance with EU Rules 7.3.2 Domestic Manufacturing Dominates the Indian Pharma Market 7.3.3 Demand for Contract Manufacturing in India: Market Forecast 2019-2029 7.4 Brazil: Contract Manufacturing Outlook 2019-2029 7.4.1 Pharmaceutical Manufacturing Regulations in Brazil 7.4.1.1 Guidelines and Regulations Proposed 7.4.2 Brazil Imports Most of its APIs 7.4.3 Brazil: Pharma Contract Manufacturing Market Forecast 2019-2029 7.5 The Russian Pharma Contract Manufacturing Market 2019-2029 7.5.1 Pharma Manufacturing Regulations in Russia 7.5.1.1 Compliance with GMP in Russia 7.5.2 How Will Demand for Contract Manufacturing Grow in Russia to 2029? 7.6 South Korea: Government Supported Growth 7.6.1 South Korea: Strict GMP Regulations 7.6.2 South Korea: Pharma Contract Manufacturing Market Forecast 2019-2029 7.7 Turkey: Domestic Market to offer Huge Growth Opportunities 7.7.1 Turkey: An Important Hub for Global Pharma Companies 7.7.2 Drug Approvals Delaying Growth of the Turkey Pharma Market 7.7.3 Turkey: Pharma Contract Manufacturing Market Forecast 2019-2029 7.8 Mexico: Emerging Market Power 7.8.1 Healthcare - A Top Priority in Mexico 7.8.2 Strategic Management of High Expectations 7.8.3 Mexico: Pharma Contract Manufacturing Market Forecast 2019-2029 8. Leading Companies in the Pharmaceutical Contract Manufacturing Market 8.1 Leading CMOs in the Pharmaceutical Contract Manufacturing Market 8.2 Catalent: Leading CMO 8.2.1 Multiple Expansions and Increased Focus on Biologic Manufacturing 8.2.2 Recent Developments 8.3 Lonza: Potential to Lead in ADC Manufacturing 8.3.1 Lonza: Expanding its Capacities to Meet Customer Demand for Biologic Manufacturing 8.3.2 Recent Developments 8.4 Evonik Degussa: Specialising in Small Molecules 8.4.1 Recent Developments 8.5 DPx Holdings - DSM and Patheon: Recent Merger Has Strengthened Their Position 8.5.1 Increasing Capacity Tactically and Expanding Worldwide 8.6 Teva: The World's Largest API Manufacturer 8.6.1 Will Teva Expand into Emerging Markets? 8.6.2 Recent Developments 8.7 Boehringer Ingelheim BioXcellence: Boehringer's Biopharma Manufacturing Division 8.7.1 Recent Developments 8.7.2 Adding New Services for Growth 8.8 Famar: A Possible Candidate for Acquisition 8.8.1 Recent Developments 8.9 Fareva: A Strategic Shift from Acquisition to Increase in Capacity 8.10 Vetter Pharma: Specialists in Aseptic Filling, Lyophilisation and Siliconisation 8.10.1 Vetter's Growth: Increasing in Capacity and Market Expansion 8.11 Mylan: A World Leader in Generics Manufacturing 8.11.1 Recent Developments 9. Pharmaceutical Contract Manufacturing Industry Trends: Qualitative Analysis from a CMO Perspective 2019-2029 9.1 Pharma Contract Manufacturing Market: Strengths and Weaknesses from a CMO Perspective 2019-2029 9.2 Pharma Contract Manufacturing Market: Opportunities and Threats from a CMO Perspective 2019-2029 9.3 Pharma Contract Manufacturing Market: STEP Analysis 2019-2029 9.3.1 Social Factors 9.3.2 New Technologies Will Drive Market Growth to 2029 9.3.2.1 Advantages of Single-Use Technologies in Biopharma Manufacturing 9.3.2.2 Green Technology in Contract Manufacturing 9.3.2.3 Drug Delivery Trends and CMOs 9.3.2.4 Biologics Are Causing Increased Demand for Lyophilisation 9.3.2.5 Improving Solubility and Stability for Small Molecules 9.3.2.6 Spray Drying as an Advantageous Alternative to Lyophilisation 9.3.2.7 Hot-Melt Extrusion: A Niche Opportunity 9.3.3 Economic Pressures 9.3.3.1 Developed-Market CMOs Facing Competition from Emerging Markets 9.3.4 Political Issues 9.3.4.1 How Will Regulatory Developments Affect CMOs? 9.4 Trends in Drug Development Affecting CMOs to 2028 9.4.1 Orphan Drug Development: Smaller Manufacturing Capacities 9.4.2 Complex Biologics: Interest in ADCs is increasing 9.4.3 How Will Biosimilar Market Growth Affect CMOs? 9.4.4 The Future of Small Molecule Outsourcing 9.5 How Will CMOs Expand in the Coming 10 Years? 9.5.1 CMO Consolidation Will Increase 9.5.2 There Will Be More Manufacturing Facilities Available for Acquisition 9.6 Developments in the Manufacturing Process 9.6.1 Rising Interest from Companies in Quality by Design (QbD) 9.6.2 A Move Towards Continuous Manufacturing 10. Pharmaceutical Contract Manufacturing Trends: Qualitative Analysis of the Pharmaceutical Contract Manufacturing Market from a Client Perspective 2019-2029 10.1 Pharma Contract Manufacturing Market: Strengths and Weaknesses from a Client Perspective 2019-2029 10.2 Pharma Contract Manufacturing Market: Opportunities and Threats from a Client Perspective 2019-2029 10.3 Important Aspects of the Outsourcing Decision 10.3.1 What Factors Will Influence CMO Selection? 10.3.2 CMO - Pharma Partnering Models 10.3.3 Strategic Partnering 10.3.4 Selecting a Local CMO vs. Offshoring 10.3.5 CMOs in Emerging Markets 10.3.6 Good Communication is Vital for Success 10.3.7 Ensuring Protection in Intellectual Property and Tech Transfer 10.3.8 Regulatory Compliance is a Key Deciding Factor for Pharma Clients 10.3.8.1 Regulatory Bodies and Outsourcing 10.3.8.2 Quality Agreement 10.3.8.3 Global Harmonisation Will Improve Compliance 10.4 Trends in Outsourcing Partnerships 2019-2029 10.4.1 Big Pharma and Outsourced Manufacturing 10.4.2 Small and Virtual Pharma Companies 10.4.3 How Will Biotech Funding Impact the Pharma Contract Manufacturing Industry to 2029? 11. Conclusions 11.1 The World Pharmaceutical Contract Manufacturing Market 11.2 Outlook for the Market to 2029 11.2.1 Rising Demand for High Value Services 2018-2029 11.2.2 Demand Will Be Highest Among Developed-Market Clients 11.3 Which New Technologies Will Stimulate Demand to 2029? Appendices Associated Visiongain Reports Visiongain Report Sales Order Form About Visiongain Visiongain report evaluation form List of Tables Table 3.1 Pharma Contract Manufacturing Market: Revenue ($bn) and Market Share (%) by Sector, 2018 Table 3.2 Pharmaceutical Contract Manufacturing Market: Overall Market Forecasts by Sector, Revenue ($bn), Annual Growth (%), CAGR (%), 2019-2029 Table 3.3 Pharma Contract Manufacturing Market: Market Shares (%), 2018-2023 Table 3.4 Pharma Contract Manufacturing Market: Market Shares (%), 2024-2029 Table 3.5 Other Services Submarket Forecast, Revenue ($bn), Annual Growth (%), CAGR (%), 2018-2029 Table 4.1 Contract API Manufacturing Submarket: Revenue ($bn) and Submarket Share (%) by Sector, 2018 Table 4.2 Contract API Manufacturing Submarket: Overall Submarket Forecasts by Sector, Revenue ($bn), Annual Growth (%), CAGR (%), 2019-2029 Table 4.3 Contract API Manufacturing Submarket Shares (%), 2018-2023 Table 4.4 Contract API Manufacturing Submarket Shares (%), 2023-2029 Table 4.5 Contract API Manufacturing Submarket: Drivers and Restraints, 2018-2029 Table 4.6 Contract Generic API Manufacturing Submarket Forecast, Revenue ($bn), Annual Growth (%), CAGR (%), 2019-2029 Table 4.7 Contract Generic API Manufacturing Submarket: Drivers and Restraints, 2019-2029 Table 4.8 Contract HPAPI Manufacturing Submarket Forecast, Revenue ($bn), Annual Growth (%), CAGR (%), 2019-2029 Table 4.9 Contract HPAPI Manufacturing Submarket: Drivers and Restraints, 2019-2029 Table 5.1 Contract FDF Manufacturing Submarket: Revenue ($bn) and Submarket Share (%) by Sector, 2018 Table 5.2 Contract FDF Manufacturing Submarket: Overall Submarket Forecasts by Sector, Revenue ($bn), Annual Growth (%), CAGR (%), 2018-2029 Table 5.3 Contract FDF Manufacturing Submarket: Segment Shares (%), 2018-2023 Table 5.4 Contract FDF Manufacturing Submarket: Segment Shares (%), 2023-2029 Table 5.5 Contract FDF Manufacturing Submarket: Drivers and Restraints, 2019-2029 Table 5.6 Contract Solid Dosage Manufacturing Submarket Forecast, Revenue ($bn), Annual Growth (%), CAGR (%) 2019-2029 Table 5.7 Contract Solid Dosage Manufacturing Submarket: Drivers and Restraints, 2018-2029 Table 5.8 Contract Injectable Dosage Manufacturing Submarket Forecast, Revenue ($bn), Annual Growth (%), CAGR (%) 2019-2029 Table 5.9 Contract Injectable Dosage Manufacturing Submarket: Drivers and Restraints, 2019-2029 Table 5.10 Selected ADCs in Development, 2018 Table 5.11 Selected CMOs Investing in ADC Manufacturing Capacity, 2018 Table 6.1 Pharma Contract Manufacturing Market: Revenues ($bn) and Market Shares (%) by Region, 2018 Table 6.2 Pharma Contract Manufacturing Market: Regional Forecasts, Revenue ($bn), Annual Growth (%), CAGR (%), 2019-2029 Table 6.3 Pharmaceutical Contract Manufacturing Market: Submarket Shares (%), 2018-2023 Table 6.4 Pharmaceutical Contract Manufacturing Market: Submarket Shares (%), 2023-2029 Table 6.5 GDUFA: Annual Fees for Domestic and Foreign Manufacturing Sites, 2015-2016 Table 6.6 US Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), Annual Growth (%), CAGR (%), 2018-2029 Table 6.7 Canada Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), Annual Growth (%), CAGR (%), 2018-2029 Table 6.8 EU Pharma Contract Manufacturing Market: Revenue ($bn) and Market Share (%) by Leading Country, 2018 Table 6.9 EU Pharma Contract Manufacturing Market: Revenue ($bn) and Market Share (%) by Leading Country, 2023 Table 6.10 EU Pharma Contract Manufacturing Market: Revenue ($bn) and Market Share (%) by Leading Country, 2029 Table 6.11 EU5 Pharma Contract Manufacturing Market: National Market Forecasts, Revenue ($bn), Annual Growth (%), CAGR (%), 2018-2029 Table 6.12 German Pharma Contract Manufacturing: Forecast, Revenue ($bn), Annual Growth (%), CAGR (%), 2018-2029 Table 6.13 Selected French Manufacturing Site Acquisitions, 2009-2013 Table 6.14 French Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), Annual Growth (%), CAGR (%), 2019-2029 Table 6.15 Italian Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), Annual Growth (%), CAGR (%), 2019-2029 Table 6.16 Spanish Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), Annual Growth (%), CAGR (%), 2019-2029 Table 6.17 UK Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), Annual Growth (%), CAGR (%), 2019-2029 Table 6.18 Japanese Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), Annual Growth (%), CAGR (%), 2019-2029 Table 7.1 Pharma Contract Manufacturing Market: Emerging Market Revenue ($bn) and Market Share (%) by Top Country, 2018 Table 7.2 Pharma Contract Manufacturing Market: Leading Emerging Market Forecasts ($bn), Annual Growth (%), CAGR (%), 2018-2029 Table 7.3 Pharma Contract Manufacturing Market: Emerging Market Shares (%), 2018-2023 Table 7.4 Pharma Contract Manufacturing Market: Emerging Market Shares (%), 2023-2029 Table 7.5 Chinese Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), Annual Growth (%), CAGR (%), 2019-2029 Table 7.6 Indian Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), Annual Growth (%), CAGR (%), 2019-2029 Table 7.7 Brazilian Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), Annual Growth (%), CAGR (%), 2019-2029 Table 7.8 Russian Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), Annual Growth (%), CAGR (%), 2019-2029 Table 7.9 South Korean Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), Annual Growth (%), CAGR (%), 2019-2029 Table 7.10 Turkey Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), Annual Growth (%), CAGR (%), 2019-2029 Table 7.11 Mexico Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), Annual Growth (%), CAGR (%), 2019-2029 Table 8.1 Catalent: Revenue ($bn), Annual Growth, CAGR, 2013-2018 Table 8.2 Lonza: Revenue (CHF bn), Annual Growth (%), CAGR (%), 2013-2018 Table 8.3 Teva: Revenue ($bn), Annual Growth (%), CAGR (%), 2012-2017 Table 8.4 Boehringer Ingelheim BioXcellence: Revenue (CHF bn), Annual Growth (%), CAGR (%), 2012-2017 Table 9.1 Pharma Contract Manufacturing Market Strengths and Weaknesses: CMO Perspective, 2019-2029 Table 9.2 Pharma Contract Manufacturing Market Opportunities and Threats: CMO Perspective, 2019-2029 Table 9.3 Pharma Contract Manufacturing Market: STEP Analysis, 2019-2029 Table 9.4 Selected Lyophilisation Service Providers Table 9.5 Lyophilisation vs. Spray Drying: A Comparison Table 9.6 Selected Biological Manufacturing Expansion, 2013-2018 Table 9.7 Selected EU-Approved Biosimilars: Manufacturers and Companies, 2018 Table 9.8 Selected CMOs Growing Faster than the Market, 2007-2012 Table 9.9 Regional Market Expansion, 2010-2017 Table 10.1 Pharma Contract Manufacturing Market Strengths and Weaknesses: Client Perspective, 2019-2029 Table 10.2 Pharma Contract Manufacturing Market Opportunities and Threats: Client Perspective, 2019-2029 Table 10.3 Benefits and Risks to Outsourcing Pharma Manufacturing Table 10.4 ICH Guidelines: Key Facts and Adoption, 2000-2014 Table 12.1 Pharma Contract Manufacturing Market: Revenue ($bn), CAGR (%), and Market Share (%) by Sector, 2018, 2023 and 2029 Table 12.2 Pharma Contract Manufacturing Market: Revenue ($bn), CAGR (%), and Market Share (%) by Region, 2018, 2023 and 2029 List of Figures Figure 1.1 Global Pharmaceutical Contract Manufacturing Market Segmentation Overview, 2019 Figure 2.1 Selected Services Offered by CMOs Figure 2.2 Major Trends Affecting Pharma Contract Manufacturing Revenue Growth, 2018-2029 Figure 3.1 Pharma Contract Manufacturing: Market Share (%) by Sector, 2018 Figure 3.2 Pharmaceutical Contract Manufacturing Market: Overall Market Forecast, Revenue ($bn), 2018-2029 Figure 3.3 Pharma Contract Manufacturing Market: Shares (%), 2024 Figure 3.4 Pharma Contract Manufacturing Market: Shares (%), 2029 Figure 3.5 Pharma Contract Manufacturing Market: Drivers, 2018-2029 Figure 3.6 Pharma Contract Manufacturing Market: Restraints, 2018-2029 Figure 3.7 Other Services Submarket Forecast, Revenue ($bn), 2018-2029 Figure 4.1 Contract API Manufacturing Submarket: Segment Shares (%) by Sector, 2018 Figure 4.2 Contract API Manufacturing Submarket Forecast, Revenue ($bn), 2019-2029 Figure 4.3 Contract API Manufacturing Submarket: Segment Shares (%), 2023 Figure 4.4 Contract API Manufacturing Submarket: Segment Shares (%), 2029 Figure 4.5 Contract Generic API Manufacturing Submarket Forecast, Revenue ($bn), 2019-2029 Figure 4.6 Contract HPAPI Manufacturing Submarket Forecast, Revenue ($bn), 2018-2029 Figure 5.1 Contract FDF Manufacturing Submarket: Segment Shares (%) by Sector, 2018 Figure 5.2 Contract FDF Manufacturing Submarket Forecast, Revenue ($bn), 2019-2029 Figure 5.3 Contract FDF Manufacturing Submarket: Segment Shares (%), 2023 Figure 5.4 Contract FDF Manufacturing Submarket: Segment Shares (%), 2029 Figure 5.5 Contract Solid Dosage Manufacturing Submarket Forecast ($bn), 2019-2029 Figure 5.6 Contract Injectable Dosage Manufacturing Submarket Forecast, Revenue ($bn), 2019-2029 Figure 6.1 Pharma Contract Manufacturing Market: Share (%) by Region, 2018 Figure 6.2 Pharmaceutical Contract Manufacturing Market: Share (%) by Region, 2023 Figure 6.3 Pharmaceutical Contract Manufacturing Market: Share (%) by Region, 2029 Figure 6.4 US Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), 2018-2029 Figure 6.5 Canada Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), 2018-2029 Figure 6.6 EU5 Pharma Contract Manufacturing Market: Share (%) by Country, 2018 Figure 6.7 EU5 Pharma Contract Manufacturing Market: Share (%) by Country, 2023 Figure 6.8 EU5 Pharma Contract Manufacturing Market: Share (%) by Country, 2029 Figure 6.9 EU5 Pharma Contract Manufacturing Market, Revenue ($bn), 2018-2029 Figure 6.10 German Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), 2018-2029 Figure 6.11 French Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), 2019-2029 Figure 6.12 Italian Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), 2018-2029 Figure 6.13 Spanish Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), 2019-2029 Figure 6.14 UK Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), 2019-2029 Figure 6.15 Japanese Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), 2019-2029 Figure 7.1 Pharma Contract Manufacturing Market: Emerging Market Share (%) by Top Country, 2018 Figure 7.2 Pharma Contract Manufacturing Market: Emerging Market Share (%) by Top Country, 2023 Figure 7.3 Pharma Contract Manufacturing Market: Emerging Market Share (%) by Top Country, 2029 Figure 7.4 Pharma Contract Manufacturing Market: Emerging Market Share (%) by Top Country, 2018, 2023 and 2029 Figure 7.5 Chinese Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), 2019-2029 Figure 7.6 Indian Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), 2019-2029 Figure 7.7 Brazilian Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), 2019-2029 Figure 7.8 Russian Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), 2019-2029 Figure 7.9 South Korean Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), 2019-2029 Figure 7.10 Turkey Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), 2019-2029 Figure 7.11 Mexico Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), 2019-2029 Figure 8.1 Catalent: Revenue ($bn), 2012-2017 Figure 8.2 Lonza: Revenue (CHF bn), 2013-2018 Figure 8.3 Teva: Revenue ($bn), 2013-2018 Figure 8.4 Boehringer Ingelheim BioXcellence: Revenue ($bn), 2012-2017 Figure 10.1 Overview of Approved ICH Manufacturing Guidelines Figure 12.1 Pharma Contract Manufacturing Market: Revenue ($bn) by Sector, 2018, 2023 and 2029 Figure 12.2 Pharma Contract Manufacturing Market: Revenue ($bn) by Region, 2018, 2023 and 2029